Viroscope – Ghril

VIROSCOPE® A Scientific Breakthrough for Health

Viroscope : An Innovative Research Project by GHRIL

VIROSCOPE® is the result of years of research conducted by GHRIL in collaboration with several internationally renowned laboratories. Developed from plant extracts and natural active ingredients, this project aims to provide an effective therapeutic solution against various inflammatory, infectious, and chronic diseases.

With a rigorous scientific approach and strict quality control, VIROSCOPE® benefits from the expertise of five specialized laboratories in the fields of microbiology, pharmacognosy, toxicology, and hydrology.

VIROSCOPE® has benefited from the expertise and control of five laboratories

Environmental Geochemistry Analysis Laboratory, University of Lome, Lome, Togo
Food Microbiology and Quality Control Laboratory (LAMICODA), University of Lome, Lome, Togo
Immunology and Immunomodulation Research Unit (UR2IM), University of Lome, Lome, Togo
Pharmacognosy and Botany Laboratory, Cheikh Anta DIOP University, Dakar, Senegal
Toxicology and Hydrology Laboratory, Cheikh Anta DIOP University, Dakar, Senegal

Active ingredients found in VIROSCOPE®

Polyphenols, hydrolyzable tannins, flavonoids, alkaloids, saponosides, and minerals are present in VIROSCOPE®, including:

Rutin: 195.37 ± 6.01mg/g of dry extract
Gallic acid: 121.31 ± 2.49mg/g of dry extract
Calcium: 8,216 ± 1 mg/kg
Magnesium: 10,389 ± 1 mg/kg
Iron: 83 ± 1 mg/kg
Zinc: 19 ±1 mg/kg

VIROSCOPE® is a liquid herbal medicine from roots, leaves, and traditional ethanol (sodabi). VIROSCOPE® is conditioned in a 300 ml bottle. VIROSCOPE® should be stored away from sunlight and out of the reach of children.

Contraindications

VIROSCOPE® should not be used when the patient is already receiving antibiotic therapy. In such cases, the patient must wait until antibiotic therapy ends before taking VIROSCOPE®
VIROSCOPE® is strictly prohibited for children under three years of age.

Indications

VIROSCOPE® is indicated for the treatment of various diseases including chronic inflammatory diseases, bacterial and fungal infections, oral and gastrointestinal wounds, gastrointestinal disorders, neuralgia, sexual impotence, and male and female infertility. In addition, VIROSCOPE® induces healthy leukocyte proliferation.

Duration of Treatment

Routes of Administration

VIROSCOPE® is for oral administration. However, VIROSCOPE® can be applied topically to the skin to threat skin wounds.

The duration of treatment with VIROSCOPE® generally varies from 10 to 20 days. For certain diseases, VIROSCOPE® may exceptionally be used for a period of 30 days.

Adults over 18 years: 40 ml, twice a day (morning and evening)
Between 7 and 18 years: 20 ml, twice a day (morning and evening)
Between 3 and 8 years: 0.5 ml, twice a day (morning and evening)

Dosage

Shake the VIROSCOPE® bottle well before use. VIROSCOPE® is authorized for pregnant and breastfeeding women. The dosage of VIROSCOPE® when administered orally are as follows: